WCA
OXFD

Whetstone Capital Advisors’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

Whetstone Capital Advisors’s Portfolio OXFD Stock Details OXFD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-16,000
Closed -$225K – 38
2015
Q1 		$225K Hold
16,000
– – 0.08% 35
2014
Q4 		$218K Hold
16,000
– – 0.1% 31
2014
Q3 		$244K Buy
+16,000
New +$245K 0.12% 30

Other funds holding OXFD

CV
Clarus Ventures Cambridge, Massachusetts $425M AUM 26.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
TAM
Tiverton Asset Management Wilimington, Delaware $2.88B AUM 5.6% 1-Year Est. Return
LPU
Lansdowne Partners (UK) London, United Kingdom $1.87B AUM 61.55% 1-Year Est. Return

Whetstone Capital Advisors's OXFD Position: Q2 2015 in Review

Whetstone Capital Advisors sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q2 2015, closing a stake of 16,000 shares — an estimated $225K sold.

Whetstone Capital Advisors first reported a position in OXFD in Q3 2014 and held it in 3 quarters. The position peaked at $244K in Q3 2014. 61 funds tracked by Wall St. Rank hold OXFD as of Q2 2015.

  • Whetstone Capital Advisors reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q2 2015 after selling out during the quarter.
  • Whetstone Capital Advisors sold 16,000 Oxford Immunotec Global PLC Ordinary Shares shares in Q2 2015, an estimated $225K.
  • Whetstone Capital Advisors first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q3 2014 and held it in 3 quarters.
  • Whetstone Capital Advisors's Oxford Immunotec Global PLC Ordinary Shares position peaked at $244K in Q3 2014.
  • 61 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q2 2015.

Based on Whetstone Capital Advisors's 13F filing for Q2 2015, filed 5 Aug 2015.